- Comprehensive portfolio for biopharmaceuticals
- Innovative primary packaging solutions and drug delivery devices
- Ready-to-Use (RTU/RTF) platform technology for reduced total costs
- Gerresheimer at CPHI 2025 in Frankfurt, Hall 8, Booth 8.OG8
Duesseldorf/Frankfurt, October 16, 2025. Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, will present its extensive portfolio of specialized primary packaging solutions, including closures and accessories, as well as innovative drug delivery devices at this year’s CPHI in Frankfurt, Germany, from October 28 to 30. The focus is on the EZ-fill Smart RTF/RTU platform for ready-to-fill (RTF) injection vials, as well as the Gx Elite RTF syringes and cartridges that ensure the highest quality and protection for sensitive biopharmaceuticals. The portfolio is complemented by COP vials (Cyclic Olefin Polymer) and syringes that safely protect sensitive active ingredients, such as mRNA therapeutics, even during cryogenic storage, down to - 80°C. With patient-friendly autoinjector Gx Inbeneo and the on-body drug delivery device Gx InPuls, Gerresheimer supports the trend toward home self-treatment. Gx InPuls is the on-body device platform used for SQ Innovation's Lasix ONYU combination product. Lasix ONYU received market approval from the FDA in October.